These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20482499)

  • 1. Endocrine disruptors and human health.
    Latini G; Knipp G; Mantovani A; Marcovecchio ML; Chiarelli F; Söder O
    Mini Rev Med Chem; 2010 Aug; 10(9):846-55. PubMed ID: 20482499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol Lett; 2020 Oct; 331():259-264. PubMed ID: 32360654
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to environmental endocrine disruptors and child development.
    Meeker JD
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):952-8. PubMed ID: 23367522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial on editorial: Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Toxicol In Vitro; 2020 Sep; 67():104862. PubMed ID: 32360642
    [No Abstract]   [Full Text] [Related]  

  • 6. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine disrupting chemicals and disease susceptibility.
    Schug TT; Janesick A; Blumberg B; Heindel JJ
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):204-15. PubMed ID: 21899826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The OBELIX project: early life exposure to endocrine disruptors and obesity.
    Legler J; Hamers T; van Eck van der Sluijs-van de Bor M; Schoeters G; van der Ven L; Eggesbo M; Koppe J; Feinberg M; Trnovec T
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1933S-1938S. PubMed ID: 21543539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine Disrupting Chemicals: Current Understanding, New Testing Strategies and Future Research Needs.
    Street ME; Audouze K; Legler J; Sone H; Palanza P
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A curated knowledgebase on endocrine disrupting chemicals and their biological systems-level perturbations.
    Karthikeyan BS; Ravichandran J; Mohanraj K; Vivek-Ananth RP; Samal A
    Sci Total Environ; 2019 Nov; 692():281-296. PubMed ID: 31349169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle.
    Dickerson SM; Gore AC
    Rev Endocr Metab Disord; 2007 Jun; 8(2):143-59. PubMed ID: 17674209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to endocrine disruptors during adulthood: consequences for female fertility.
    Rattan S; Zhou C; Chiang C; Mahalingam S; Brehm E; Flaws JA
    J Endocrinol; 2017 Jun; 233(3):R109-R129. PubMed ID: 28356401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Maternal-Neonatal Steroids With Early Pregnancy Endocrine Disrupting Chemicals and Pregnancy Outcomes.
    Banker M; Puttabyatappa M; O'Day P; Goodrich JM; Kelley AS; Domino SE; Smith YR; Dolinoy DC; Song PXK; Auchus RJ; Padmanabhan V
    J Clin Endocrinol Metab; 2021 Mar; 106(3):665-687. PubMed ID: 33280001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonally active agents in the environment: a state-of-the-art review.
    Anwer F; Chaurasia S; Khan AA
    Rev Environ Health; 2016 Dec; 31(4):415-433. PubMed ID: 27487487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why endocrine disrupting chemicals (EDCs) challenge traditional risk assessment and how to respond.
    Futran Fuhrman V; Tal A; Arnon S
    J Hazard Mater; 2015 Apr; 286():589-611. PubMed ID: 25646754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General Challenges and Recommendations for the Water Quality Criteria of Endocrine Disrupting Chemicals (EDCs).
    Liu D; Hong Y; Feng C; Yan Z; Bai Y; Xu Y
    Bull Environ Contam Toxicol; 2022 Jun; 108(6):995-1000. PubMed ID: 35322278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational prediction models for assessing endocrine disrupting potential of chemicals.
    Sakkiah S; Guo W; Pan B; Kusko R; Tong W; Hong H
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2018; 36(4):192-218. PubMed ID: 30633647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.